---
figid: PMC3936782__nihms554811f1
figtitle: Canonical signal transduction cascades and mood stabilizer targets in bipolar
  disorder
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3936782
filename: nihms554811f1.jpg
figlink: /pmc/articles/PMC3936782/figure/F1/
number: F1
caption: 'Canonical signal transduction cascades and mood stabilizer targets in bipolar
  disorder. On the left side of the figure, monoaminergic (serotonin, norepinephrine,
  and dopamine) neurotransmitter receptors activates the intracellular phosphoinositide
  second messenger/signal transduction cascade. Phospholipases enzymatically degrade
  phosphoinositides to inositol triphosphate (IP3) and diacylglycerol (DAG). Lithium
  (and potentially mood-stabilizing antiepileptic drugs) noncompetitively inhibits
  inositol monophosphatase (IMPase), which decreases myoinositol uptake and phosphoinositide
  production in the brain and/or peripheral tissues. Mood stabilizers also inhibit
  multiple other overactive nodes in intracellular pathways: protein kinase C (PKC),
  myristolated alanine-rich C kinase substrate (MARCKS), and extracellular regulated
  protein kinase (ERK)/mitogen-activated protein kinase (MAPK), which coalesces to
  decrease cAMP-response element binding protein (CREB) phosphorylation and CRE-mediated
  gene transcription. On the right side of the figure, overactivation of the canonical
  Wnt/Fz/Dvl/GSK-3β signaling pathway in BD commences when Wnt glycoprotein extracellularly
  binds to its cognate Frizzled (Fz) receptor. Intracellular Fz activation stimulates
  Disheveled and GSK-3β phosphorylation, which phosphorylates β-catenin and promotes
  the formation of a lysosomal destruction complex with the other proteins (axin/APC/GSK-3β/β-catenin).
  Lithium is a potent GSK-3β inhibitor. Therefore, lithium reduces GSK-3β phosphorylation,
  decreases β-catenin phosphorylation, and dissociates the destruction complex, which
  stabilizes β-catenin for nuclear translocation and increases the transcription of
  β-catenin target genes. Li, lithium; AED, antiepileptic mood stabilizer medication;
  IMPase, inositol monophosphatase; 5-HT, 5-hydroxytryptamine (serotonin); NE, norepinephrine;
  DA, dopamine; PLCβ, phospholipase C-beta; IP3, inositol triphosphate; PIP2, phosphoinositide-4,5-bisphosphate;
  PKC, protein kinase C; CAMKII, calcium-calmodulin dependent protein kinase II; PKA,
  protein kinase A; MAPK, mitogen-activated protein kinase; ERK, extracellular-regulated
  kinase; CREB, cyclic adenosine monophosphate (cAMP)-response element binding protein;
  LEF/TCF, lymphoid enhancer factor/T-cell factor; Fz, frizzled; Dvl, disheveled;
  APC, adenosis polyposis coli; GSK-3b, glycogen synthase kinase-3 beta; β-Cat, beta-catenin.'
papertitle: 'Second messenger/signal transduction pathways in major mood disorders:
  moving from membrane to mechanism of action, part II: bipolar disorder.'
reftext: Mark J. Niciu, et al. CNS Spectr. ;18(5):242-251.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9808573
figid_alias: PMC3936782__F1
figtype: Figure
redirect_from: /figures/PMC3936782__F1
ndex: 81c62b31-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3936782__nihms554811f1.html
  '@type': Dataset
  description: 'Canonical signal transduction cascades and mood stabilizer targets
    in bipolar disorder. On the left side of the figure, monoaminergic (serotonin,
    norepinephrine, and dopamine) neurotransmitter receptors activates the intracellular
    phosphoinositide second messenger/signal transduction cascade. Phospholipases
    enzymatically degrade phosphoinositides to inositol triphosphate (IP3) and diacylglycerol
    (DAG). Lithium (and potentially mood-stabilizing antiepileptic drugs) noncompetitively
    inhibits inositol monophosphatase (IMPase), which decreases myoinositol uptake
    and phosphoinositide production in the brain and/or peripheral tissues. Mood stabilizers
    also inhibit multiple other overactive nodes in intracellular pathways: protein
    kinase C (PKC), myristolated alanine-rich C kinase substrate (MARCKS), and extracellular
    regulated protein kinase (ERK)/mitogen-activated protein kinase (MAPK), which
    coalesces to decrease cAMP-response element binding protein (CREB) phosphorylation
    and CRE-mediated gene transcription. On the right side of the figure, overactivation
    of the canonical Wnt/Fz/Dvl/GSK-3β signaling pathway in BD commences when Wnt
    glycoprotein extracellularly binds to its cognate Frizzled (Fz) receptor. Intracellular
    Fz activation stimulates Disheveled and GSK-3β phosphorylation, which phosphorylates
    β-catenin and promotes the formation of a lysosomal destruction complex with the
    other proteins (axin/APC/GSK-3β/β-catenin). Lithium is a potent GSK-3β inhibitor.
    Therefore, lithium reduces GSK-3β phosphorylation, decreases β-catenin phosphorylation,
    and dissociates the destruction complex, which stabilizes β-catenin for nuclear
    translocation and increases the transcription of β-catenin target genes. Li, lithium;
    AED, antiepileptic mood stabilizer medication; IMPase, inositol monophosphatase;
    5-HT, 5-hydroxytryptamine (serotonin); NE, norepinephrine; DA, dopamine; PLCβ,
    phospholipase C-beta; IP3, inositol triphosphate; PIP2, phosphoinositide-4,5-bisphosphate;
    PKC, protein kinase C; CAMKII, calcium-calmodulin dependent protein kinase II;
    PKA, protein kinase A; MAPK, mitogen-activated protein kinase; ERK, extracellular-regulated
    kinase; CREB, cyclic adenosine monophosphate (cAMP)-response element binding protein;
    LEF/TCF, lymphoid enhancer factor/T-cell factor; Fz, frizzled; Dvl, disheveled;
    APC, adenosis polyposis coli; GSK-3b, glycogen synthase kinase-3 beta; β-Cat,
    beta-catenin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - 5-HT1B
  - 5-HT1A
  - 5-HT2A
  - da
  - nAChRalpha2
  - Ne
  - fz
  - Galphas
  - dsh
  - norpA
  - slmb
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - CaMKII
  - Axn
  - sgg
  - Apc
  - Apc2
  - Fs(3)Apc
  - ac
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - CrebB
  - CrebA
  - arm
  - MKP-4
  - p38b
  - rl
  - Erk7
  - pan
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GNAS
  - GNAL
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CAMK2G
  - AXIN1
  - AXIN2
  - MARCKS
  - APC
  - PROC
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - HNF4A
  - Myoinositol
  - 5-HT
  - Cancer
---
